BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 12769727)

  • 1. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
    Barbaro G; Klatt EC
    Curr Pharm Des; 2003; 9(18):1475-81. PubMed ID: 12769727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral therapy and the cardiovascular system: the heart of the matter.
    Barbaro G
    Pharmacology; 2003 Dec; 69(4):177-9. PubMed ID: 14624056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection, highly active antiretroviral therapy and the cardiovascular system.
    Barbaro G
    Cardiovasc Res; 2003 Oct; 60(1):87-95. PubMed ID: 14522410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiology and AIDS--HAART and the consequences.
    Hoffmann C; Jaeger H
    Ann N Y Acad Sci; 2001 Nov; 946():130-44. PubMed ID: 11762982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.
    Barbaro G
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):337-43. PubMed ID: 16101566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection, antiretroviral therapy and cardiovascular risk.
    Barbaro G
    J Cardiovasc Risk; 2002 Oct; 9(5):295-300. PubMed ID: 12394324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
    Barbaro G
    Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
    Barbaro G; Barbarini G
    Chemotherapy; 2006; 52(4):161-5. PubMed ID: 16675900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic syndrome associated with HIV and highly active antiretroviral therapy.
    Barbaro G; Iacobellis G
    Curr Diab Rep; 2009 Feb; 9(1):37-42. PubMed ID: 19192423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic toxicities of antiretroviral therapy.
    Herman JS; Easterbrook PJ
    Int J STD AIDS; 2001 Sep; 12(9):555-62; quiz 563-4. PubMed ID: 11516363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.
    Barbaro G
    Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic complications of antiretroviral therapy in children.
    Leonard EG; McComsey GA
    Pediatr Infect Dis J; 2003 Jan; 22(1):77-84. PubMed ID: 12544413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and skeletal complications of HIV infection: the price of success.
    Morse CG; Kovacs JA
    JAMA; 2006 Aug; 296(7):844-54. PubMed ID: 16905789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
    Leclercq P; Blanc M
    Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk.
    Barbaro G
    Am J Ther; 2006; 13(3):248-60. PubMed ID: 16772767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic abnormalities in patients with HIV infection].
    Rodríguez-Carranza SI; Aguilar-Salinas CA
    Rev Invest Clin; 2004; 56(2):193-208. PubMed ID: 15377073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2004 May; 95(5):265-75. PubMed ID: 15202680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.
    Anuurad E; Semrad A; Berglund L
    Metab Syndr Relat Disord; 2009 Oct; 7(5):401-10. PubMed ID: 19355810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.